BE1003407A3 - Agents de blocage neuromusculaire. - Google Patents

Agents de blocage neuromusculaire. Download PDF

Info

Publication number
BE1003407A3
BE1003407A3 BE9100665A BE9100665A BE1003407A3 BE 1003407 A3 BE1003407 A3 BE 1003407A3 BE 9100665 A BE9100665 A BE 9100665A BE 9100665 A BE9100665 A BE 9100665A BE 1003407 A3 BE1003407 A3 BE 1003407A3
Authority
BE
Belgium
Prior art keywords
neuromuscular
geometric
optical isomers
neuromuscular blocking
locking agents
Prior art date
Application number
BE9100665A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of BE1003407A3 publication Critical patent/BE1003407A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Led Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Paper (AREA)

Abstract

L'isomère 1R-cis,1'R-cis d'un sel de 2',2'-(3,11-dioxo-4,10-dioxatridécylène)-bis(1,2,3,4-tétrahydro-6,7-diméthoxy-2-méthyl-1-vératrylisoquino-léinium sensiblement exempt de ses autres isomères géométriques et optiques s'est révélé avoir une combinaison avantageuse de propriétés pharmacologiques, notamment une plus grande activité de blocage neuromusculaire et une plus faible activité de libération de l'histamine pour des taux équivalents de blocage neuromusculaire, que le mélange connu des isomères géométriques et optiques.
BE9100665A 1990-07-13 1991-07-12 Agents de blocage neuromusculaire. BE1003407A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015473A GB9015473D0 (en) 1990-07-13 1990-07-13 Neuromuscular blocking agents

Publications (1)

Publication Number Publication Date
BE1003407A3 true BE1003407A3 (fr) 1992-03-17

Family

ID=10679071

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9100665A BE1003407A3 (fr) 1990-07-13 1991-07-12 Agents de blocage neuromusculaire.

Country Status (40)

Country Link
EP (1) EP0539470B1 (fr)
JP (3) JP2823356B2 (fr)
KR (1) KR0174284B1 (fr)
AT (1) ATE138369T1 (fr)
AU (2) AU8190491A (fr)
BE (1) BE1003407A3 (fr)
CA (1) CA2087104C (fr)
CH (1) CH683427A5 (fr)
CY (1) CY1985A (fr)
CZ (1) CZ284645B6 (fr)
DE (2) DE69119768T2 (fr)
DK (2) DK0539470T3 (fr)
ES (2) ES2083315B1 (fr)
FI (2) FI982342L (fr)
FR (1) FR2665701B1 (fr)
GB (2) GB9015473D0 (fr)
GE (1) GEP19981163B (fr)
GR (1) GR3020792T3 (fr)
HK (1) HK80196A (fr)
HU (2) HU218766B (fr)
IE (1) IE912440A1 (fr)
IL (1) IL98814A (fr)
IT (1) IT1249677B (fr)
LT (1) LT3317B (fr)
LU (1) LU88198A1 (fr)
LV (1) LV10432B (fr)
MX (1) MX9203220A (fr)
MY (1) MY113017A (fr)
NL (1) NL9120017A (fr)
NZ (1) NZ238964A (fr)
PA (1) PA8401801A1 (fr)
PL (1) PL167302B1 (fr)
PT (1) PT98306B (fr)
RU (1) RU2104005C1 (fr)
SA (1) SA91120073B1 (fr)
SE (1) SE9300052D0 (fr)
SK (1) SK279907B6 (fr)
UA (1) UA32536C2 (fr)
WO (1) WO1992000965A1 (fr)
ZA (1) ZA915468B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
DE19535762A1 (de) * 1995-09-26 1997-03-27 Basf Ag Verfahren zur Racematspaltung
US5684154A (en) * 1996-02-16 1997-11-04 Abbott Laboratories Process for the preparation and isolation of atracurium besylate
DE69830157T2 (de) * 1997-03-25 2006-05-11 Avera Pharmaceuticals, Inc., San Diego Substituierte isochinoline als ultrakurz wirkende neuromuskuläre blocker
AU2008222298A1 (en) 2007-03-08 2008-09-12 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
WO2008117271A1 (fr) * 2007-03-26 2008-10-02 Chemagis Ltd. Procédé de séparation de sels de (1r, 1'r)-atracurium
AU2008273724B2 (en) 2007-05-01 2013-05-23 Chemagis Ltd. Process for Producing Cisatracurium and Associated Intermediates
WO2008132748A1 (fr) 2007-05-01 2008-11-06 Chemagis Ltd. Procédé de fabrication de composés de cisatracurium et intermédiaires associés
AU2008264802A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
CN101337936B (zh) * 2007-07-06 2011-03-23 江苏恒瑞医药股份有限公司 一种用柱色谱法纯化苯磺酸阿曲库铵的方法
CN101337935B (zh) * 2007-07-06 2011-01-12 江苏恒瑞医药股份有限公司 一种用两相萃取法纯化苯磺酸阿曲库铵的方法
WO2009057086A1 (fr) 2007-10-29 2009-05-07 Chemagis Ltd. Nouveaux sels de r,r'-atracurium
IT1396543B1 (it) * 2008-07-16 2012-12-14 Farmabios Spa Processo per la purificazione di bloccanti neuromuscolari
WO2010128518A2 (fr) * 2009-05-04 2010-11-11 Gland Pharma Limited Nouveau procédé pour la préparation de bésylate de cisatracurium
CN107056700A (zh) * 2017-04-18 2017-08-18 哈尔滨医科大学 一种四氢异喹啉类化合物外消旋体的半量拆分法
CN112939862B (zh) * 2021-02-03 2023-01-10 江苏诚信药业有限公司 一种苯磺顺阿曲库铵杂质h的分离制备方法及其应用
CN115850169B (zh) * 2022-10-17 2025-04-04 上海医药集团(本溪)北方药业有限公司 苯磺顺阿曲库铵杂质及其中间体的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579822A (en) * 1976-10-29 1980-11-26 Wellcome Found Tetrahydroisoquinolinium muscle relaxants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
ES454090A1 (es) * 1976-12-09 1978-01-16 Wellcome Found Un metodo para preparar compuestos heterociclicos.
DE3328664A1 (de) * 1983-08-09 1985-02-21 Robert Bosch Gmbh, 7000 Stuttgart Zuckerziehmaschine
BG41897A1 (en) * 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
US9524531B2 (en) 2011-05-09 2016-12-20 Microsoft Technology Licensing, Llc Extensibility features for electronic communications

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579822A (en) * 1976-10-29 1980-11-26 Wellcome Found Tetrahydroisoquinolinium muscle relaxants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, CHIMIE THERAPEUTIQUE, vol. 19, no. 5, septembre 1984, pages 441-450, Châtenay-Malabry, FR; J.B. STENLAKE et al.: "Biodegradable neuromuscular blocking agents. Part 6. Stereochemical studies on atracurium and related polyalkylene di-esters" *

Also Published As

Publication number Publication date
WO1992000965A1 (fr) 1992-01-23
SA91120073B1 (ar) 2002-10-26
EP0539470A1 (fr) 1993-05-05
LTIP274A (en) 1994-10-25
DE69119768D1 (de) 1996-06-27
HU218766B (hu) 2000-11-28
FI982342A0 (fi) 1998-10-28
AU687481B2 (en) 1998-02-26
UA32536C2 (uk) 2001-02-15
EP0539470B1 (fr) 1996-05-22
NZ238964A (en) 1992-06-25
MX9203220A (es) 1992-07-01
ES2083315B1 (es) 1997-11-16
SK383392A3 (en) 1999-05-07
IT1249677B (it) 1995-03-09
ATE138369T1 (de) 1996-06-15
GB9224764D0 (en) 1993-02-03
IL98814A (en) 1995-12-08
JPH05508648A (ja) 1993-12-02
FI103507B (fi) 1999-07-15
LV10432B (en) 1995-08-20
PT98306A (pt) 1992-06-30
DK149692D0 (da) 1992-12-14
GB9015473D0 (en) 1990-08-29
PA8401801A1 (es) 1997-01-03
SE9300052L (sv) 1993-01-12
PT98306B (pt) 1999-01-29
GR3020792T3 (en) 1996-11-30
FR2665701A1 (fr) 1992-02-14
HU211169A9 (en) 1995-11-28
CY1985A (en) 1997-09-05
JPH10139763A (ja) 1998-05-26
CH683427A5 (fr) 1994-03-15
FI982342A7 (fi) 1998-10-28
ES2088009T3 (es) 1996-08-01
FI925894A0 (fi) 1992-12-28
JP3462165B2 (ja) 2003-11-05
GB2260763A (en) 1993-04-28
AU1134695A (en) 1995-03-30
KR0174284B1 (ko) 1999-02-18
DE4191541T1 (de) 1993-05-13
MY113017A (en) 2001-11-30
JP2001058981A (ja) 2001-03-06
NL9120017A (nl) 1993-04-01
ITRM910518A1 (it) 1993-01-12
DK149692A (da) 1992-12-14
DE69119768T2 (de) 1996-10-02
HK80196A (en) 1996-05-17
SE9300052D0 (sv) 1993-01-12
JP2823356B2 (ja) 1998-11-11
RU2104005C1 (ru) 1998-02-10
GB2260763B (en) 1994-01-05
HU9300052D0 (en) 1993-04-28
SK279907B6 (sk) 1999-05-07
ITRM910518A0 (it) 1991-07-12
HUT67613A (en) 1995-04-28
PL167302B1 (en) 1995-08-31
LV10432A (lv) 1995-02-20
ES2083315A1 (es) 1996-04-01
AU8190491A (en) 1992-02-04
IE912440A1 (en) 1992-01-15
DK0539470T3 (da) 1996-08-05
FR2665701B1 (fr) 1995-03-03
LU88198A1 (fr) 1993-05-17
LT3317B (en) 1995-06-26
ZA915468B (en) 1993-03-31
PL297606A1 (fr) 1992-07-13
CZ284645B6 (cs) 1999-01-13
IL98814A0 (en) 1992-07-15
FI103507B1 (fi) 1999-07-15
FI982342L (fi) 1998-10-28
CA2087104A1 (fr) 1992-01-14
FI925894L (fi) 1992-12-28
CZ383392A3 (en) 1994-02-16
CA2087104C (fr) 1998-08-18
GEP19981163B (en) 1998-07-06

Similar Documents

Publication Publication Date Title
BE1003407A3 (fr) Agents de blocage neuromusculaire.
KR880009910A (ko) 리폭시게네이즈 억제 화합물
KR870003782A (ko) 활성성분으로서 2-알키닐아데노신을 함유하는 항고혈압제
FI930745A0 (fi) Heterocykliska foereningar och deras framstaellning och anvaendning
KR950000683A (ko) 2-피페라지논 화합물 및 그의 용도
KR890011851A (ko) 이소 키놀린 유도체, 그 제조방법 및 사용방법
RU93004869A (ru) Нервно-мышечный блокатор, его получение, фармацевтический состав и способ обеспечения нервно-мышечной блокады у животных
UA19151A (uk) Спосіб одержаhhя оптичhо активhого (+)-4-деметоксидауhоміциhоhу
BG96194A (bg) Метод за получаване на простагландинови производни
ES8405779A1 (es) Un procedimiento para preparar derivados de 1-fenoxi-3-(4-fenilpiperazino)-2-propanol.
FR2361326A1 (fr) Derives de cyclohexane utiles comme agents odoriferants
KR850002987A (ko) 2-아자사이클로알킬티오페넴 유도체의 제조방법
FR2441386A2 (fr) Composes triazinones pour bloquer la stimulation nerveuse a frequence elevee
KR910011851A (ko) 벤젠 축합 유도체
RU98123592A (ru) Способ лечения бокового амиотрофического склероза

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: S.A. *GLAXO WELLCOME BELGIUM

Effective date: 20110712